Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Enterprise Value: 2009-2025

Historic Enterprise Value for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to $17.6 million.

  • Rockwell Medical's Enterprise Value fell 83.22% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.7 million, marking a year-over-year decrease of 154.07%. This contributed to the annual value of $44.3 million for FY2024, which is 3.30% up from last year.
  • As of Q3 2025, Rockwell Medical's Enterprise Value stood at $17.6 million, which was up 66.79% from $10.6 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Enterprise Value ranged from a high of $104.9 million in Q3 2024 and a low of -$19.8 million during Q2 2022.
  • Its 3-year average for Enterprise Value is $39.7 million, with a median of $41.5 million in 2024.
  • Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 160.20% in 2022, then spiked by 580.84% in 2024.
  • Over the past 5 years, Rockwell Medical's Enterprise Value (Quarterly) stood at $16.1 million in 2021, then tumbled by 160.20% to -$9.7 million in 2022, then spiked by 543.07% to $42.9 million in 2023, then grew by 3.30% to $44.3 million in 2024, then tumbled by 83.22% to $17.6 million in 2025.
  • Its Enterprise Value stands at $17.6 million for Q3 2025, versus $10.6 million for Q2 2025 and $21.2 million for Q1 2025.